Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Colorectal Cancer Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by iOMEDICO AG
Sponsor:
Collaborators:
Arbeitskreis Klinische Studien
Arbeitsgemeinschaft Internistische Onkologie (AIO)
Information provided by (Responsible Party):
iOMEDICO AG
ClinicalTrials.gov Identifier:
NCT00910819
First received: May 28, 2009
Last updated: March 14, 2014
Last verified: March 2014

May 28, 2009
March 14, 2014
September 2006
March 2020   (final data collection date for primary outcome measure)
Course of Antineoplastic Treatment [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Course of Antineoplastic Treatment [ Time Frame: 5 years ] [ Designated as safety issue: Yes ]
Complete list of historical versions of study NCT00910819 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Colorectal Cancer Registry
Prospective and Retrospective Observation of the Adjuvant and Palliative Treatment Strategies in the Therapy of Colorectal Cancer in Germany

The purpose of this registry is to record information on the antineoplastic treatment of colorectal cancer in Germany. The registry will follow up patients for five years. It will identify common therapeutic sequences and changes in the treatment of the disease. The impact of nutrition (CoNut) and physical activity (CoNut) on the course of the adjuvant disease will be examined, as well as long-term effects of adjuvant treatment (CoTox) and the final phase of the palliative process (CoLife). Based on the available data a prognostic score will be developed.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Colorectal cancer patients undergoing antineoplastic treatment.

Colorectal Cancer
Other: non-interventional
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
6500
March 2020
March 2020   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Colorectal cancer
  • 18 years and older
  • Antineoplastic treatment

Exclusion Criteria:

  • No colorectal cancer
  • Below 18 years
  • No antineoplastic treatment
Both
18 Years and older
No
Contact: Stefanie Kopfmann +49 761 15242 - 0 info@iomedico.com
Contact: Holger Hartmann, PhD +49 761 15242 - 0 info@iomedico.com
Germany
 
NCT00910819
IOM TKK
No
iOMEDICO AG
iOMEDICO AG
  • Arbeitskreis Klinische Studien
  • Arbeitsgemeinschaft Internistische Onkologie (AIO)
Study Chair: Roland Schnell, MD
iOMEDICO AG
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP